The unanimous buying by three active managers suggests a shared positive view on AbbVie's earnings trajectory, reinforced by the recent guidance update. Monitor upcoming Q3 2026 earnings for confirmation of the $3.73-$3.77 adjusted EPS range and any further IPR&D charges.
Executive Summary
Three institutional asset managers added or doubled their AbbVie positions in Q3 2026, with aggregate buying of $120.3M and no selling. The cluster follows AbbVie's October 5 guidance update, which narrowed full-year adjusted EPS to $13.76-$13.96, incorporating a $216M IPR&D charge. The buying is concentrated in active managers, suggesting conviction in AbbVie's fundamentals despite the deal-related expense.
Key Financial Metrics
Institutional Positions
Net institutional flow: $120.3M
▲ Buyers (3)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Wealth Enhancement Advisory Services | ADD | +32.4% | $180.2M | $62.8M |
| Congress Asset Management | DOUBLED | +262.7% | $3.2M | $2.3M |
| Vontobel Holding | DOUBLED | +102.7% | $105.0M | $55.2M |
Key Facts
- 3 institutions accumulated $120.3M in net new AbbVie positions during Q3 2026
- Wealth Enhancement Advisory Services added 32.4% to its position, now worth $180.2M
- Vontobel Holding more than doubled its stake, adding $55.2M in value
- Congress Asset Management nearly tripled its small position (+262.7%)
- No institutional sellers were identified in this cluster
- The cluster follows AbbVie's Oct 5 guidance update: FY2026 adjusted EPS $13.76-$13.96
Financial Impact
Three active asset managers accumulated $120.3M in AbbVie shares during Q3 2026, with zero selling. The largest buyer, Wealth Enhancement Advisory Services, added $62.8M to its position.
Risk Factors
- 13F data has a 45-day reporting lag; positions may have been adjusted since quarter-end
- The cluster is small (3 funds) and may not represent broad institutional sentiment
- The guidance update included a $216M IPR&D charge, which could signal further deal-related dilution
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-ABBV-2026-Q3 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 9d ago | Institutional Cluster | $282.68 | awaiting T+20 | — | — |
Oct 15, 2026 10d ago | 8-K | $285.42 | awaiting T+20 | — | — |
Oct 5, 2026 20d ago | 8-K | $265.06 | awaiting T+20 | — | — |
Sep 28, 2026 28d ago | Court Ruling | $263.29 | awaiting T+20 | — | — |
Sep 14, 2026 6w ago | Court Ruling | $261.43 $272.69 | ▲ +4.30% | ▲ +1.33% | — |
Sep 3, 2026 7w ago | 8-K | $260.21 $262.82 | ▲ +1.00% | ▲ +2.19% | — |
Aug 5, 2026 11w ago | 8-K | $243.87 $260.21 | ▲ +6.70% | ▲ +6.10% | — |
Aug 2, 2026 12w ago | Institutional Cluster | $245.10 $256.42 | ▲ +4.62% | ▲ +3.38% | — |
Aug 3, 2026 12w ago | Court Ruling | $243.80 $259.99 | ▲ +6.64% | ▲ +7.88% | — |
Jul 31, 2026 12w ago | 8-K | $250.94 $255.48 | ▲ +1.81% | ▼ −1.18% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers